Report Detail
Global (United States, European Union and China) Breast Cancer Liquid Biopsy Market Research Report 2019-2025
- RnM3666151 |
- 13 August, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Other
Breast Cancer Liquid Biopsy can be usually used in breast biopsy, based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers.
In 2019, the market size of Breast Cancer Liquid Biopsy is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Breast Cancer Liquid Biopsy.
This report studies the global market size of Breast Cancer Liquid Biopsy, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Breast Cancer Liquid Biopsy production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
QIAGEN
Roche Diagnostics
Bio-Rad Laboratories
Myriad Genetics
Menarini Silicon Biosystems
Genomic Health
Thermo Fisher Scientific
Illumina
Biocept
Trovagene
Guardant Health
RainDance Technologies
MDx Health
Market Segment by Product Type
Circulating Tumor Cells (CTCs)
Cell-Free DNA (CfDNA)
Extracellular Vesicles (EVs)
Other Circulating Biomarkers
Market Segment by Application
Hospitals
Diagnostic Centers
Laboratories
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Breast Cancer Liquid Biopsy status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Breast Cancer Liquid Biopsy manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Breast Cancer Liquid Biopsy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Breast Cancer Liquid Biopsy Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Circulating Tumor Cells (CTCs)
- 1.3.3 Cell-Free DNA (CfDNA)
- 1.3.4 Extracellular Vesicles (EVs)
- 1.3.5 Other Circulating Biomarkers
- 1.4 Market Segment by Application
- 1.4.1 Global Breast Cancer Liquid Biopsy Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Diagnostic Centers
- 1.4.4 Laboratories
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Breast Cancer Liquid Biopsy Production Value 2014-2025
- 2.1.2 Global Breast Cancer Liquid Biopsy Production 2014-2025
- 2.1.3 Global Breast Cancer Liquid Biopsy Capacity 2014-2025
- 2.1.4 Global Breast Cancer Liquid Biopsy Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Breast Cancer Liquid Biopsy Market Size CAGR of Key Regions
- 2.2.2 Global Breast Cancer Liquid Biopsy Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Breast Cancer Liquid Biopsy Capacity by Manufacturers
- 3.1.2 Global Breast Cancer Liquid Biopsy Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Breast Cancer Liquid Biopsy Revenue by Manufacturers (2014-2019)
- 3.2.2 Breast Cancer Liquid Biopsy Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Breast Cancer Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
- 3.3 Breast Cancer Liquid Biopsy Price by Manufacturers
- 3.4 Key Manufacturers Breast Cancer Liquid Biopsy Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Breast Cancer Liquid Biopsy Market
- 3.6 Key Manufacturers Breast Cancer Liquid Biopsy Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Circulating Tumor Cells (CTCs) Production and Production Value (2014-2019)
- 4.1.2 Cell-Free DNA (CfDNA) Production and Production Value (2014-2019)
- 4.1.3 Extracellular Vesicles (EVs) Production and Production Value (2014-2019)
- 4.1.4 Other Circulating Biomarkers Production and Production Value (2014-2019)
- 4.2 Global Breast Cancer Liquid Biopsy Production Market Share by Type
- 4.3 Global Breast Cancer Liquid Biopsy Production Value Market Share by Type
- 4.4 Breast Cancer Liquid Biopsy Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Breast Cancer Liquid Biopsy Consumption by Application
6 Production by Regions
- 6.1 Global Breast Cancer Liquid Biopsy Production (History Data) by Regions 2014-2019
- 6.2 Global Breast Cancer Liquid Biopsy Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Breast Cancer Liquid Biopsy Production Growth Rate 2014-2019
- 6.3.2 United States Breast Cancer Liquid Biopsy Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Breast Cancer Liquid Biopsy Import & Export
- 6.4 European Union
- 6.4.1 European Union Breast Cancer Liquid Biopsy Production Growth Rate 2014-2019
- 6.4.2 European Union Breast Cancer Liquid Biopsy Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Breast Cancer Liquid Biopsy Import & Export
- 6.5 China
- 6.5.1 China Breast Cancer Liquid Biopsy Production Growth Rate 2014-2019
- 6.5.2 China Breast Cancer Liquid Biopsy Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Breast Cancer Liquid Biopsy Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Breast Cancer Liquid Biopsy Consumption by Regions
- 7.1 Global Breast Cancer Liquid Biopsy Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Breast Cancer Liquid Biopsy Consumption by Type
- 7.2.2 United States Breast Cancer Liquid Biopsy Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Breast Cancer Liquid Biopsy Consumption by Type
- 7.3.2 European Union Breast Cancer Liquid Biopsy Consumption by Application
- 7.4 China
- 7.4.1 China Breast Cancer Liquid Biopsy Consumption by Type
- 7.4.2 China Breast Cancer Liquid Biopsy Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Breast Cancer Liquid Biopsy Consumption by Type
- 7.5.2 Rest of World Breast Cancer Liquid Biopsy Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 QIAGEN
- 8.1.1 QIAGEN Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Breast Cancer Liquid Biopsy
- 8.1.4 Breast Cancer Liquid Biopsy Product Introduction
- 8.1.5 QIAGEN Recent Development
- 8.2 Roche Diagnostics
- 8.2.1 Roche Diagnostics Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Breast Cancer Liquid Biopsy
- 8.2.4 Breast Cancer Liquid Biopsy Product Introduction
- 8.2.5 Roche Diagnostics Recent Development
- 8.3 Bio-Rad Laboratories
- 8.3.1 Bio-Rad Laboratories Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Breast Cancer Liquid Biopsy
- 8.3.4 Breast Cancer Liquid Biopsy Product Introduction
- 8.3.5 Bio-Rad Laboratories Recent Development
- 8.4 Myriad Genetics
- 8.4.1 Myriad Genetics Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Breast Cancer Liquid Biopsy
- 8.4.4 Breast Cancer Liquid Biopsy Product Introduction
- 8.4.5 Myriad Genetics Recent Development
- 8.5 Menarini Silicon Biosystems
- 8.5.1 Menarini Silicon Biosystems Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Breast Cancer Liquid Biopsy
- 8.5.4 Breast Cancer Liquid Biopsy Product Introduction
- 8.5.5 Menarini Silicon Biosystems Recent Development
- 8.6 Genomic Health
- 8.6.1 Genomic Health Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Breast Cancer Liquid Biopsy
- 8.6.4 Breast Cancer Liquid Biopsy Product Introduction
- 8.6.5 Genomic Health Recent Development
- 8.7 Thermo Fisher Scientific
- 8.7.1 Thermo Fisher Scientific Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Breast Cancer Liquid Biopsy
- 8.7.4 Breast Cancer Liquid Biopsy Product Introduction
- 8.7.5 Thermo Fisher Scientific Recent Development
- 8.8 Illumina
- 8.8.1 Illumina Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Breast Cancer Liquid Biopsy
- 8.8.4 Breast Cancer Liquid Biopsy Product Introduction
- 8.8.5 Illumina Recent Development
- 8.9 Biocept
- 8.9.1 Biocept Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Breast Cancer Liquid Biopsy
- 8.9.4 Breast Cancer Liquid Biopsy Product Introduction
- 8.9.5 Biocept Recent Development
- 8.10 Trovagene
- 8.10.1 Trovagene Company Details
- 8.10.2 Company Description and Business Overview
- 8.10.3 Production and Revenue of Breast Cancer Liquid Biopsy
- 8.10.4 Breast Cancer Liquid Biopsy Product Introduction
- 8.10.5 Trovagene Recent Development
- 8.11 Guardant Health
- 8.12 RainDance Technologies
- 8.13 MDx Health
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Breast Cancer Liquid Biopsy Capacity, Production Forecast 2019-2025
- 9.1.2 Global Breast Cancer Liquid Biopsy Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Breast Cancer Liquid Biopsy Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Breast Cancer Liquid Biopsy Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Breast Cancer Liquid Biopsy Production Forecast by Type
- 9.7.2 Global Breast Cancer Liquid Biopsy Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Breast Cancer Liquid Biopsy Sales Channels
- 10.2.2 Breast Cancer Liquid Biopsy Distributors
- 10.3 Breast Cancer Liquid Biopsy Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on BreastCancerLiquidBiopsy. Industry analysis & Market Report on BreastCancerLiquidBiopsy is a syndicated market report, published as Global (United States, European Union and China) Breast Cancer Liquid Biopsy Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of BreastCancerLiquidBiopsy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
